Rilpivrine is BCS class II drug used for treatment of HIV infection. The drug has low aqueous
solubility (0.0166 mg/ml) and dissolution rate leading to low bioavailability (32%). Aim of this …

The antiretroviral agents rilpivirine (RPV) and cabotegravir (CAB) are approved as a
combined treatment regimen against human immunodeficiency virus (HIV). To fully …

The (E)‐isomer of rilpivirine is an approved antiretroviral drug used to treat human
immunodeficiency virus. A simple, fast, accurate, and precise analytical method is required …

Developing a single analytical method for estimation of individual drug from a multidrug
composition is a very challenging task. A complexation, derivatization, extraction …

A simple, accurate, rapid, and stability‐indicating RP‐HPLC method for a combination of
tenofovir disoproxil fumarate, emtricitabine, and rilpivirine has been developed and …

In the present study a simple isocratic reverse phase HPLC method was developed for the
estimation of rilpivirine in pharmaceutical formulation. The separation was carried out using …

Rilpivirine is a new second-generation non-nucleoside reverse transcriptase inhibitor used
as an anti-viral drug. A new stability indicating reverse phase ultrafast liquid …

In this work, a novel method for the simultaneous estimate of Montelukast (MONT) and
Ebastine (EBAS) in bulk drugs was developed using Central Composite Design (CCD). A …

Rilpivirine is used to treat human immunodeficiency virus type 1 (HIV-1). A new stability
indicating RP-UPLC method has been developed for the estimation of Rilpivirine and N …

Background: The present research work comprises of the Stability Indicating RP-HPLC
newlineanalytical method development and validation for selected drugs andamp; …